Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2026-01-22 00:00:00 ET · period of report 2026-01-20 · accession 0001628280-26-003149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-22 | 2026-01-22 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $4.17 | -34.8K | 196.2K | -15% | -$145.1K |
| DM | 2026-01-22 | 2026-01-20 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +115.4K | 231.0K | +100% | — |
| DM | 2026-01-22 | 2026-01-20 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | $0.00 | -115.4K | 69.4K | -62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-22 | S | D | 34,799 | $4.17 | 196,154 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote |
| 2 | Common | Common Stock | 2026-01-20 | M | A | 37,069 | — | 161,532 | D | — | — | (F1) Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 3 | Common | Common Stock | 2026-01-20 | M | A | 8,888 | — | 124,463 | D | — | — | (F1) Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 4 | Common | Common Stock | 2026-01-20 | M | A | 69,421 | — | 230,953 | D | — | — | (F1) Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| 5 | Derivative | Restricted Stock Units | 2026-01-20 | M | D | 37,069 | $0.00 | 37,069 | D | — · — to — | 37,069 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F6) On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |
| 6 | Derivative | Restricted Stock Units | 2026-01-20 | M | D | 8,888 | $0.00 | 0 | D | — · — to — | 8,888 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F5) On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |
| 7 | Derivative | Restricted Stock Units | 2026-01-20 | M | D | 69,421 | $0.00 | 69,421 | D | — · — to — | 69,421 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F7) On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |